Skip to main content
main-content
Top

04-06-2017 | Pertuzumab | Article

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

von Minckwitz G et al. N Engl J Med 2017; 377(2):122-131. doi:10.1056/NEJMoa1703643

Please log in to get access to this content

Related topics